Analyst Ratings for Allscripts Healthcare Solutions Inc. (MDRX)Updated: 2017-07-26
Shares of Allscripts Healthcare Solutions Inc. (NASDAQ:MDRX) have received a consensus rating of Overweight from Wall Street analysts. About 30 days ago, MDRX was issued an average rating of Overweight.
9 analysts declared MDRX a buy, 2 gave an overweight rating, 14 issued a hold rating, 0 issued an underweight rating, and 1 gave a sell rating. Compared to three months ago, there has been an increase of 0 in the number of analysts with a positive outlook on the stock. During this time, the number of analysts bearish on the stock has increased by 0.
MDRX was given price targets by several analysts. The most optimistic price target was 17, which equates to a potential upside of 35.89 percent. The lowest price target was 11, implying a possible loss of -12.07 percent. It is advisable to not rely only on price targets or ratings, as these can be biased for some stocks.
In the last 30 days, analysts have changed their quarterly earnings estimates upwards by an average of 0 percent. This can be compared with the average change in earnings estimates over the past 3 months, which is 0 percent. Over the past 30 days, FY earnings estimates have also changed upwards by 0 percent. Expanding the time horizon to 3 months, the average change in fiscal year estimates becomes 3.26 percent.
Another thing investors often look at is the level of agreement among analysts' revisions. 0 analysts have revised their quarterly estimates upwards in the past 30 days, while 0 analysts revised their estimates downwards. Also over the last month, 0 analysts increased their estimates for the FY earnings, while 0 analysts made negative revisions to their fiscal year's estimates.
In the trailing 52-weeks, MDRX hit 15.17 at the highest peak, while it's lowest trading point was 9.80. Currently the stock is 27.65 percent higher than its low, and 17.53 percent lower than its 52-week high. MDRX has a P/E ratio of 0. Investors typically compare the P/E ratio to a company's peers in the industry. The MDRX value stock report compares MDRX to some of its peers using value stock charts. The stock has a market capitalization of $2.25 billion. MDRX is estimated to release their earnings results for the quarter on 0000-00-00, days from today.